Terbutaline sulfoconjugate: Characterization and urinary excretion monitored by LC/ESI-MS/MS

Drug Testing and Analysis

Volumn 1, Issue 11-12, 2009, Pages 568-575

  Orlovius, A K ^a,b   Guddat, S ^a   Parr, M K ^a   Kohler, M ^a   Gutschow M ^b   Thevis, M ^a   Schanzer W ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Beta 2 agonists; Doping control; LC ESI MS MS; Phase II metabolism; Sulfate conjugate

Indexed keywords

BIOMOLECULES; DIAGNOSIS; ESTERS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHYSIOLOGY; SCREENING; SULFUR COMPOUNDS;

BETA-2 AGONIST; DOPING CONTROL; LC MS/MS(ESI); LC-ESI-MS/MS; LC/ESI-MS/MS; PHASE II; PHASE-II METABOLISM; SULFATE CONJUGATES; SYNTHESISED; TERBUTALINE;

METABOLITES;

BENZYL DERIVATIVE; PHENOL; PHENOL DERIVATIVE; SULFATE; TERBUTALINE;

ACCURACY; ADULT; ARTICLE; CHEMICAL STRUCTURE; DRUG EXCRETION; DRUG STRUCTURE; ELECTRON SPIN RESONANCE; ESTERIFICATION; FEMALE; GLUCURONIDATION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCREENING; SYNTHESIS; URINALYSIS; URINARY EXCRETION;

EID: 77953427175     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.84     Document Type: Article

References (24)

1. G Hochhaus, H Mollmann, Int. J. Clin. Pharmacol. 1992, 30, 342.
2. World Anti-Doping Agency, The 2009 Prohibited List. Available at www.wada-ama.org/rtecontent/document/2009-Prohibited-List-ENG-Final-20-Sept 08.pdf, accessed 8 April 2009.
3. D. S Davies, C. F George, E Blackwel, M. E Conolly, C. T Dollery, Br. J. Clin. Pharmacol. 1974, 1, 129.
4. K Persson, Xenobio. 1972, 2, 375.
5. G. M Pacifici, M Eligi, L Giuliani, Eur. J. Clin. Pharmacol. 1993, 45, 483.
6. K Tegner, H. T Nilsson, C. G. A Persson, K Persson, A Ryrfeldt, Eur. J. Respir. Dis. 1984, 65, 93.
7. H. T Nilsson, K Tegner, K Persson, Xenobio. 1972, 2, 363.
8. Y Hornblad, E Ripe, P. O Magnusson, K Tegner, Eur.J.Clin.Pharmacol. 1976, 10, 9.
9. R. S Bandurski, L. G Wilson, C. L Squires, J. Am. Chem. Soc. 1956, 78, 6408.
10. T. Walle, U. K Walle, Br. J. Clin. Pharmacol. 1990, 30, 127.
11. L Borgstrom, L Nyberg, S Jonsson, C Lindberg, J Paulson, Br. J. Clin. Pharmacol. 1989, 27, 49.
12. M Thevis, G Opfermann, W Schanzer, J. Mass Spectrom. 2003, 38, 1197.
13. L Damasceno, R Ventura, J Ortuno, J Segura, J.Mass Spectrom. 2000, 35, 1285.
14. C Brunelli, C Bicchi, A Di Stilo, A Salomone, M Vincenti, J. Sep. Sci. 2006, 29, 2765.
15. L Damasceno, R Ventura, J Cardoso, J Segura, J.Chromatogr.B 2002, 780, 61.
16. M. K Henze, G Opfermann, H Spahn-Langguth, W Schanzer, J. Chromatogr. B 2001, 751, 93.
17. M Roig, R Berges, R Ventura, K. D Fitch, A. R Morton, J Segura, J. Chromatogr. B 2002, 768, 315.
18. F. M Kaspersen, C. A. A Vanboeckel, Xenobio. 1987, 17, 1451.
19. A. B Roy, in Sulfatation of Drugs and Related Compounds, (Ed: G. J Mulder), CRC Press: Boca Raton, USA, 1981, pp. 5-30.
20. N Shima, H Tsutsumi, T Kamata, M Nishikawa, M Katagi, A Miki, H Tsuchihashi, J. Chromatogr. B 2006, 830, 64.
21. M Thevis, W Schanzer, J. Chromatogr. Sci. 2005, 43, 22.
22. D Thieme, J Grosse, R Lang, R.K Mueller, A Wahl, J. Chromatogr. B 2001, 757, 49.
23. K Levsen, H. M Schiebel, B Behnke, R Dotzer, W Dreher, M Elend, H Thiele, J. Chromatogr. A 2005, 1067, 55.
24. M Thevis, G Opfermann, W Schanzer, Eur. J. Mass Spectrom. 2004, 10, 673.